Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr;14(8):e70903.
doi: 10.1002/cam4.70903.

Retrospective Case-Cohort Study on Risk Factors for Developing Distant Metastases in Women With Breast Cancer

Affiliations

Retrospective Case-Cohort Study on Risk Factors for Developing Distant Metastases in Women With Breast Cancer

Serena Bertozzi et al. Cancer Med. 2025 Apr.

Abstract

Objective: This study aimed to identify risk factors associated with the development of metastases in breast cancer patients, to investigate survival rates, and the relationship between local recurrences and distant metastases.

Methods: This retrospective case-cohort study included women with breast cancer who were treated at a certified Breast Unit between 2001 and 2015. Cases who developed distant metastases were compared to controls based on diagnosis year, stage, and age at diagnosis. Comprehensive information on patient characteristics, tumor biology, and treatment options was gathered.

Results: The study included 412 patients who developed distant metastases and 433 controls who remained metastasis-free over a median follow-up of 150 months (interquartile range 87-202). The 20-year overall survival was 99.23% for the control group and 23.62% for those with metastasis (p < 0.01). Significant risk factors for metastasis included lobular invasive carcinoma (odds ratio (OR) 2.26, p < 0.001), triple-negative subtype (OR 4.06, p = 0.002), high tumor grade (OR 2.62, p = 0.004), larger tumor size (OR 1.02, p < 0.001), lymph node involvement (p < 0.001), and loco-regional recurrence (OR 4.32, p < 0.001). Progesterone receptor (PR) expression was protective (OR 0.52, 95% confidence interval 0.34-0.81, p = 0.003). Machine learning models supported these findings, though their clinical significance was limited.

Conclusions: Lobular invasive carcinoma, specific tumor subtypes, high grade, large tumor size, lymph node involvement, and loco-regional recurrence are all significant risk factors for distant metastasis, whereas PR expression is protective. The potential of machine learning in predicting metastasis was explored, showing promise for future personalized risk assessment.

Keywords: breast cancer metastasis; distant recurrence prediction; machine learning; personalized treatment; progesterone receptor; risk factors; tumor subtype.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
(A) Survival curves between the group that developed distant metastases and the group that did not. In this analysis, only deaths from cancer were considered. Weighted Cox model, p < 0.05. (B) This plot shows the variable importance estimated with a Random Forest model. (C) Network of correlations between loco‐regional recurrences and the different types of distant metastases.

References

    1. Parkes A., Clifton K., Al‐Awadhi A., et al., “Characterization of Bone Only Metastasis Patients With Respect to Tumor Subtypes,” npj Breast Cancer 4 (2018): 2. - PMC - PubMed
    1. Hudis C. A. and Gianni L., “Triple‐Negative Breast Cancer: An Unmet Medical Need,” Oncologist 16, no. Suppl 1 (2011): 1–11. - PubMed
    1. Bertozzi S., Londero A. P., Cedolini C., et al., “Prevalence, Risk Factors, and Prognosis of Peritoneal Metastasis From Breast Cancer,” Springerplus 4 (2015): 688. - PMC - PubMed
    1. Bertozzi S., Londero A. P., Bernardi S., and Cedolini C., “Applicability of the Notthingham Prognostic Index for Predicting the Survival of Triple‐Negative Invasive Breast Cancer in a Single Italian Center,” European Journal of Gynaecological Oncology 40 (2019): 787–790.
    1. Lobbezoo D. J. A., van Kampen R. J. W., Voogd A. C., et al., “Prognosis of Metastatic Breast Cancer: Are There Differences Between Patients With De Novo and Recurrent Metastatic Breast Cancer?,” British Journal of Cancer 112 (2015): 1445–1451. - PMC - PubMed